Trial Outcomes & Findings for Sedation and Pain (The Effect of IV Sedation on Pain Perception) (NCT NCT00853333)
NCT ID: NCT00853333
Last Updated: 2014-06-26
Results Overview
Mechanical Slide Algometer (www.decisionaidsonline.com), Range: "No Pain Sensation" (1) to " Most Intense Sensation Imaginable" (10) 10 point scale. Change Time Points: Baseline (no sedation), Sedation. Same Day Intervention.
COMPLETED
NA
86 participants
Sedation
2014-06-26
Participant Flow
Participant milestones
| Measure |
Dexmedetomidine
Sedation Arm 1, Dose adjusted to Sedation Self-rating of 50% on Sedation Scale.
|
Midazolam
Sedation Arm 2, Dose adjusted to Sedation Self-rating of 50% on Sedation Scale.
|
Propofol
Sedation Arm 3, Dose adjusted to Sedation Self-rating of 50% on Sedation Scale.
|
|---|---|---|---|
|
Overall Study
STARTED
|
28
|
27
|
31
|
|
Overall Study
COMPLETED
|
28
|
27
|
31
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Sedation and Pain (The Effect of IV Sedation on Pain Perception)
Baseline characteristics by cohort
| Measure |
Dexmedetomidine
n=28 Participants
|
Midazolam
n=27 Participants
|
Propofol
n=31 Participants
|
Total
n=86 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
24.74 years
STANDARD_DEVIATION 4.47 • n=5 Participants
|
24.46 years
STANDARD_DEVIATION 4.64 • n=7 Participants
|
25.83 years
STANDARD_DEVIATION 5.41 • n=5 Participants
|
25.01 years
STANDARD_DEVIATION 4.84 • n=4 Participants
|
|
Sex: Female, Male
Female
|
15 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
14 Participants
n=5 Participants
|
45 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
13 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
17 Participants
n=5 Participants
|
41 Participants
n=4 Participants
|
|
Region of Enrollment
United States
|
28 participants
n=5 Participants
|
27 participants
n=7 Participants
|
31 participants
n=5 Participants
|
86 participants
n=4 Participants
|
PRIMARY outcome
Timeframe: SedationMechanical Slide Algometer (www.decisionaidsonline.com), Range: "No Pain Sensation" (1) to " Most Intense Sensation Imaginable" (10) 10 point scale. Change Time Points: Baseline (no sedation), Sedation. Same Day Intervention.
Outcome measures
| Measure |
Dexmedetomidine
n=28 Participants
|
Midazolam
n=27 Participants
|
Propofol
n=31 Participants
|
|---|---|---|---|
|
Pain Rating Change
|
-0.253 units on a scale
Standard Error 0.168
|
0.762 units on a scale
Standard Error 0.171
|
-0.346 units on a scale
Standard Error 0.159
|
Adverse Events
Dexmedetomidine
Midazolam
Propofol
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place